Point-of-Care (POC) Coagulation Testing Market Trends Support A 4.1% CAGR Outlook Through The Forecast Period

The point-of-care coagulation testing market is on track for steady expansion as healthcare increasingly embraces decentralized and home-based monitoring solutions. Advances in technology and growing demand for rapid, accurate testing are setting the stage for significant developments in this sector over the coming years. Let's explore the market size projections, key players, emerging trends, and the main segments driving growth in this evolving field.

Forecasted Growth and Market Size of the Point-of-Care Coagulation Testing Market
The point-of-care (POC) coagulation testing market is projected to grow steadily, reaching a value of $1.52 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 4.1%. Several factors contribute to this upward trend, including a shift toward decentralized coagulation monitoring and increased adoption of electrochemical detection methods. Additionally, the rising number of emergency and trauma procedures, broader access through retail and direct tender channels, and a strong focus on reducing turnaround times while improving therapeutic outcomes are all driving the market forward. Key trends expected to influence this growth involve rapid bedside coagulation testing in critical care settings, expanded use of POC devices for anticoagulation therapy monitoring, a growing preference for portable and handheld analyzers, wider utilization in home care environments, and demand for real-time clinical decision support through near-patient testing.

Download a free sample of the Point-of-Care (POC) Coagulation Testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Major Companies Leading the Point-of-Care Coagulation Testing Market
The competitive landscape of the point-of-care coagulation testing market features several prominent companies such as Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., and EKF Diagnostics Holdings plc. An important development occurred in December 2023, when Switzerland-based F. Hoffmann-La Roche AG acquired LumiraDx Ltd., a UK-based POC coagulation testing provider, for $350 million. This acquisition strengthens Roche's diagnostics portfolio and enhances its ability to deliver patient-centered, point-of-care healthcare solutions spanning the entire patient journey.

Collaborations and Innovations Fueling Market Expansion in POC Coagulation Testing
Companies in this market are actively pursuing innovation through partnerships that enable the development of connected POC coagulation solutions. Strategic collaborations help firms combine expertise and resources to maintain a competitive edge. For example, in January 2023, Jana Care, a US-based developer of biomarker assays for digital health platforms, partnered with Roche Diagnostics of Switzerland. Their joint effort focuses on creating a point-of-care blood testing platform aimed at screening for chronic kidney disease and heart failure. This innovative system will allow patients to conduct blood tests at home, with results remotely reviewed by healthcare providers, highlighting the shift toward patient-centric and remote healthcare models.

View the full Point-of-Care (POC) Coagulation Testing market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Segments Defining the Point-of-Care Coagulation Testing Market
This market is broken down into several critical segments to better understand its dynamics:
1) Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) Distribution Channel: Direct Tenders, Retail
3) End-User: Hospitals, Clinics, Home Care

Further, the technology segment is subdivided into:
- Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
- Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
- Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection

These segments highlight the diversity of technologies and distribution methods that support the expanding use of point-of-care coagulation testing in various healthcare settings.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.